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Cognitivedeclineaﬀectsoneintwentypeopleovertheageof65.Thereisoftenapaucityofcluesastotheunderlyingpathology,and
whilethediagnosiswillusuallyprovetobeeitherAlzheimer’sdiseaseorvasculardementia,theremaybeclinicalfeaturessuggesting
rarer alternatives. This case of a 71-year-old lady with a 3-month history of progressive cognitive decline illustrates clinical features
suggestive of Creutzfeltd-Jakob disease such as rapid decline in conscious level and myoclonic jerking. Diagnosis was conﬁrmed
by 3 means: (1) Electroencephalogram demonstrating periodic sharp wave complexes, (2) MRI brain showing cortical ribboning
and high signal in the caudate nucleus, and (3) presence of protein S100 and protein14-3-3 in the cerebrospinal ﬂuid. Postmortem
brain histology conﬁrmed a typical spongiform encephalopathy. Establishing an underlying aetiology is dementia is important
not only for prognostic reasons but in order to detect potentially reversible causes. In cases of an atypical dementing illness our
proposed investigations may assist in conﬁrming or excluding underlying Creutzfeltd-Jakob disease.
1.Introduction
Cognitive decline is a frequent cause of presentation to pri-
maryorsecondarycare,especiallyintheelderly:oneintwen-
ty people over the age of 65 develops dementia. As in the
following case, there is often a paucity of clues as to the
underlying pathology, and while the diagnosis will usually
prove to be either Alzheimer’s disease, dementia with Lewy
bodies, or vascular dementia, there may be clinical and lab-
oratory features suggesting rarer alternatives.
2. Case History
A 71-year-old Caucasian female presented with a 3-month
history of cognitive decline, particularly short-term memory
lossfollowedbyintermittentdullheadaches,whichworsened
progressively over the week prior to admission. She had type
2 diabetes and mild renal insuﬃciency but had previously
been self-caring and independently mobile. Initial examina-
tion revealed no focal neurological signs but her Abbreviated
Mental Test Score (AMTS) was 6/10. The only abnormal
blood results were ESR 53, creatinine 154mM, and glucose
11.4mM. CT brain revealed a small region of subtle low
attenuation in the right corona radiata, consistent with an
infarct. This was a recent event as CT brain performed by her
GP as part of investigations for memory loss two months
earlier was normal. She was transferred to a nearby stroke
rehabilitation hospital but her conscious level declined pro-
gressively over the following two weeks. She became increas-
ingly confused, agitated, and withdrawn. This was initially
attributed to an underlying chest infection but she did not
improve with antibiotics. She was therefore readmitted to
o u rs e r v i c ef o rf u r t h e ri n v e s t i g a t i o n .
On reassessment, 15 days after her initial presentation,
she was apyrexial and haemodynamically stable but barely
conscious with GCS of 8/15. Pupils were pinpoint, and she2 Case Reports in Medicine
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Figure 1: (a) Initial EEG demonstrating slow wave activity inconclusive for status epilepticus, (b) periodic sharp wave complexes demon-
strated on EEG.
exhibited occasional myoclonic jerking of the limbs but no
other focal neurology. EEG (Figure 1(a)) showed general
slowing with some sharpened slow waves, sometimes fol-
lowed by periods of suppressed EEG activity. This was not
thought diagnostic of any speciﬁc entity but possibly con-
sistent with a postepileptic state, and she was treated with
phenytoin and later sodium valporate. Brain MRI brain
showed the focal area of infarction in the deep white matter
of right parietal regions, as noted previously on CT, together
with cerebral atrophy, but no other abnormality. CSF was
acellular,withnormalprotein,glucoseandnegativecytology,
and negative HSV PCR. The syndrome of rapidly progressive
cortical dysfunction with myoclonus without prominent fo-
calneurologicalsignsormajorMRIbrainscanabnormalities
raised the possibility of CJD. CSF was sent to the CJD Sur-
veillance Unit in Edinburgh (http://www.cjd.ed.ac.uk/)a n d
revealed a signiﬁcant increase in protein S100 to 1.0 (refer-
ence range <0.41). Protein “14-3-3” wasalso detected. At day
43 after initial presentation repeat EEG now showed periodic
sharp waves followed by suppression, characteristic of CJD
(Figure 1(b)).RepeatMRIrevealedhighsignalinthecaudate
andbasalganglia,andribbon-likecorticalhighsignalchange
on the FLAIR sequence, also classic characteristics of CJD
(Figure 2). Her conscious level failed to improve and the my-
oclonusprogressed.Shedevelopedahospital-acquiredpneu-
monia and died seven weeks after the initial presentation.
Postmortem examination of the brain demonstrated typical
spongiform encephalopathy consistent with CJD. Neuronal
loss and amyloid plaques were not mentioned in the report
(Figure 3). There was no reference to the corona radiata vas-
cular lesion. If further studies were to have been conducted,
migration on Western blot analysis would have been help-
ful.
3. Discussion
CJD is a rare illness characterised by rapidly progressive
dementia, ataxia, myoclonus, and akinetic, mutism [1]. At
present the most reliable incidence ﬁgures come from Aus-
tria, where autopsy rates are over 90% for deaths in hospital.
For the year 1995, an incidence of 1.38 per million was re-
ported [2]. By far the most common form of CJD in elderly
patients is sporadic CJD but cases of variant CJD have also
been reported [3]. In all cases of CJD intracellular deposition
of insoluble, abnormal form (PrPsc) of a normal soluble cel-
lular protein (PrPc) in neurones is observed [4]. The disease
has a particular predilection for the basal ganglia but neu-
rones of the cerebral cortex and cerebellum are also com-
monly aﬀected, leading to dementia, progressive akinesia,
ataxia, and forms of epilepsy, notably myoclonus.
A large number of alternative diagnoses are possible
when CJD is suspected, including rapidly progressive Alz-
heimer’sdisease,vasculardementia,anddementiawithLewy
bodies [2]. However, myoclonus, ataxia, akinetic mutism,
and visual hallucinations are signiﬁcantly more common in
CJD. Seizures ranging from simple seizures to status epilepti-
cus, as in our case, have also been reported in CJD. Sporadic
CJD patients have been misdiagnosed with non-convulsive
status epilepticus (NCSE), highlighting that CJD should be
considered a diﬀerential diagnosis in patients with status
epilepticus [5, 6]. Generally, Alzheimer’s disease is slowly
progressive with a duration of 8–10 years, and neurological
signs appear in advanced disease. Vascular dementia usually
has a stepwise deterioration in cognitive function and can be
associated with focal signs. Parkinsonism, visual hallucina-
tions, and ﬂuctuations in cognitive impairment are the main
characteristics of dementia with Lewy bodies [4]. Other in-
ﬂammatory conditions such as Hashimoto’s encephalitis, ce-
rebral vasculitis, neoplasia, storage diseases, and granuloma-
tous disease must also be considered [6].
CJD progresses to death after a median illness duration
of 5 months [7]. The median age of disease onset is generally
lower for CJD patients than for Alzheimer’s disease (66 years
versus 71 years). Vascular dementia and dementia with Lewy
bodies both have a similar age of onset of 68 years [4].
The World Health Organisation criteria for the diagnosis
of sporadic CJD classiﬁes possible CJD as rapidly progressive
dementia of less than a two-year duration, with 2 of either
(a) myoclonus (b) visual or cerebellar problems (c) pyrami-
dal or extrapyramidal features or (d) akinetic mutism. Prob-
able CJD must meet the criteria for possible CJD plus either
a typical EEG or positive 14-3-3 in the CSF. CJD can only be
classiﬁed as “deﬁnite CJD” once it has been neuropathologi-
cally conﬁrmed.Case Reports in Medicine 3
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Figure 2: MRI scan demonstrating: (a) high signal in the caudate
nucleus and (b) cortical ribboning.
4.Electroencephalogram
EEG studies can be a useful diagnostic aid in CJD. The char-
acteristic feature is periodic sharp wave complexes (see Fig-
ure 1(b)). Although not pathognomonic, they are present in
52%–58% of patients with CJD but only around 6% of cases
ofAlzheimer’s,Lewybody,andvasculardementia[4,7].EEG
is also useful for ruling out nonconvulsive status epilepticus.
5.MagneticResonance Imaging
The most consistent ﬁnding on MRI is bilateral areas of hy-
perintensity in the caudate nuclei and putamina, with recent
studies quoting speciﬁcity of up to 93% (see Figure 2). Hy-
perintensityisalsoseentoalesserextentinthecortex,globus
pallidus, and thalamus [8]. Some studies have proposed to
amend clinical diagnostic criteria to include MRI ﬁndings,
which showed to be 83% speciﬁc in one study [9]. Signal
intensity changes in the cerebral cortex, called “cortical rib-
boning,” can also be seen but are less frequent. The degree
of atrophy of the cortex and basal ganglia correlates with
the disease duration [1]. Thus underlying the potentially im-
portant role in premortem diagnosis of sporadic CJD.
6. CerebrospinalFluid
CSF examination is imperative as a raised CSF cell count is
the best single marker for a potentially treatable inﬂamma-
tory process [6]. More detailed assessment for the presence
ofprotein14-3-3isthemostvaluablefactorindiﬀerentiating
CJD and Alzheimer’s disease. The presence and persistence
of 14-3-3 is indicative of the more rapid brain destruction in
CJD. It has a high sensitivity for sporadic CJD in the range of
88% to 97% and a speciﬁcity of 92% [4, 7]. Protein S100 is
slightly inferior to 14-3-3 with an average sensitivity of 87%
[10].
7.BrainBiopsy
Brain biopsy is generally regarded as a procedure of last
resort due to perceived low diagnostic yield and possibility
Figure 3: Spongiform encephalopathy (H&E stain).
of serious complications including haemorrhage, infection,
and seizures [5]. However, a study of 90 brain biopsies un-
dertaken between 1989 and 2003 for the investigation of de-
mentia found that 57% were diagnostic, the most frequent
diagnosis being Alzheimer’s disease (18%) while CJD was
also frequently found, at 12%. A potentially reversible in-
ﬂammatory cause was identiﬁed in 10% of cases [6]. Brain
biopsy can therefore resolve diagnostic uncertainly but
around 10% of people can expect to experience a compli-
cation and it is therefore generally reserved for younger pa-
tients, where there is a greater possibility of ﬁnding a revers-
ible condition.
8. Summary
It is likely that CJD is underdiagnosed. In patients with
rapidly progressive dementia we would recommend serial
brain MRI and EEG examinations, and in particular, CSF ex-
amination for protein 14-3-3 as the three principal investiga-
tions. Although CJD is currently a fatal disease, establishing
this diagnosis is not only essential in order to and exclude
other treatable causes but also to be able to give patients
and relatives accurate information about their diagnosis and
prognosis.
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